Partial
Mostly Aligned
Patient Risk:
Low
Summary
The AI claims largely align on core label topics (brand name, ED/BPH indications, nitrates and antihypertensive interactions, and standard ED dosing options). However, multiple statements are not supported by the labeling (e.g., generic/product marketing claims, prescription status, online/red-flag guidance, and clinician confirmation of dose) and critical safety details (such as explicit nitrate-washout timing and boxed warnings) are omitted.
Category Scores
Accurate Statements
Cialis is the brand name for tadalafil.
2.1
In some strengths, tadalafil is indicated for BPH.
2.4
Tadalafil can interact with nitrates used for chest pain.
4.1
Tadalafil can interact with some blood-pressure medications.
5.6
If you take heart medications or nitrates, ask a clinician before using tadalafil.
4.1, 5.6
For as-needed ED use, tadalafil is taken before sex, with dosing commonly based on a prescribed schedule (often 10 mg or 20 mg starting options).
2.1
For daily use, tadalafil is commonly taken once per day at a consistent dose (often 5 mg for some patients).
2.2, 2.4
Unsupported Statements
In the US, a 'Cialis generic' usually means generic tadalafil, the active ingredient in Cialis.
Not stated in the provided labeling sections.
These products are marketed as tadalafil tablets.
Not stated in the provided labeling sections.
Most commonly 20 mg as-needed dose.
Label allows 20 mg but does not specify 'most common'.
Dosing depends on the specific generic product.
Not stated in the provided labeling sections.
When a product is sold as generic tadalafil, it contains the same active ingredient.
Not explicitly stated in the labeling sections.
Generic tadalafil is intended to work the same way for erectile dysfunction.
Not stated in the labeling sections.
Legitimate generic tadalafil in the US requires a prescription.
Not stated in the labeling sections.
Any site or seller offering 'no prescription' tadalafil is a common red flag for unsafe or unapproved products.
Not stated in the labeling sections.
Clinician/pharmacist can confirm the correct dose and check interactions.
Not stated in the labeling sections.
Be cautious with online offers that advertise Cialis or tadalafil from abroad without prescriptions.
Not stated in the labeling sections.
Be cautious with products that don’t clearly name the active ingredient and dose.
Not stated in the labeling sections.
Be cautious with counterfeit packaging or inconsistent tablet appearance.
Not stated in the labeling sections.
Be cautious with unusually low prices compared with normal US pricing.
Not stated in the labeling sections.
Contradictions
Important Omissions
Explicit nitrate washout timing after tadalafil dosing (e.g., 48 hours) and boxed warning emphasis; broader safety details (e.g., alpha-blocker interactions) as described in the label.
Importance:
High
Safety Assessment
Potential Patient Risk:
Low
Core safety concepts (nitrate interactions, antihypertensive interactions, and dosing regimens) align with labeling; presence of non-label assertions reduces exact safety fidelity.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Non-label claims (prescription status, generic/marketing assertions, online red flags) and incomplete safety details (nitrate washout timing).
Suggested Improvement
Limit claims to topics explicitly covered by the labeling. Include explicit contraindication/washout details for nitrates and address boxed warnings where applicable. Avoid extrapolating 'most common' dosing without label support.